KLK3 and cancer: Since the mid 1980s, the widespread use of the prostate-specific antigen (PSA) has substantially shaped the management of this cancer, but its overdiagnosis and overtreatment has gained increasing attention after a controversial debate on the PSA-based early detection and screening approach [2,3].